|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/475 | |
| C07K 14/65 | |||
| C07K 16/12 | |||
| C07K 16/40 | |||
| C12N 9/90 | |||
| G01N 33/573 | |||
| G01N 33/74 | |||
| C07K 16/22 |
| (11) | Patento numeris | 2705053 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12717787.1 |
| Europos patento paraiškos padavimo data | 2012-05-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/058208 |
| Data | 2012-05-04 |
| (87) | Numeris | WO 2012/150321 |
| Data | 2012-11-08 |
| (30) | Numeris | Data | Šalis |
| 11164957 | 2011-05-05 | EP | |
| 12155742 | 2012-02-16 | EP |
| (72) |
ANDRES, Herbert, DE
DUEFEL, Hartmut, DE
GERG, Michael, DE
KOWALEWSKY, Frank, DE
SCHOLZ, Christian, DE
SCHRAEML, Michael, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Roche Diagnostics GmbH, Sandhofer Stra e 116, 68305 Mannheim, DE |
| (54) | AN ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1 |
| AN ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1 |